IL145946A0 - Novel crystalline forms of a macrolide antibiotic - Google Patents

Novel crystalline forms of a macrolide antibiotic

Info

Publication number
IL145946A0
IL145946A0 IL14594600A IL14594600A IL145946A0 IL 145946 A0 IL145946 A0 IL 145946A0 IL 14594600 A IL14594600 A IL 14594600A IL 14594600 A IL14594600 A IL 14594600A IL 145946 A0 IL145946 A0 IL 145946A0
Authority
IL
Israel
Prior art keywords
crystalline forms
novel crystalline
macrolide antibiotic
macrolide
antibiotic
Prior art date
Application number
IL14594600A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL145946A0 publication Critical patent/IL145946A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL14594600A 1999-05-18 2000-04-14 Novel crystalline forms of a macrolide antibiotic IL145946A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13464499P 1999-05-18 1999-05-18
PCT/IB2000/000463 WO2000069874A1 (en) 1999-05-18 2000-04-14 Novel crystalline forms of a macrolide antibiotic

Publications (1)

Publication Number Publication Date
IL145946A0 true IL145946A0 (en) 2002-07-25

Family

ID=22464300

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14594600A IL145946A0 (en) 1999-05-18 2000-04-14 Novel crystalline forms of a macrolide antibiotic
IL145946A IL145946A (en) 1999-05-18 2001-10-15 Crystalline forms of history of azithromycin, their preparation and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145946A IL145946A (en) 1999-05-18 2001-10-15 Crystalline forms of history of azithromycin, their preparation and pharmaceutical preparations containing them

Country Status (43)

Country Link
US (1) US6583274B1 (xx)
EP (1) EP1189912B1 (xx)
JP (1) JP3897983B2 (xx)
KR (1) KR100474229B1 (xx)
CN (1) CN1203084C (xx)
AP (1) AP2001002325A0 (xx)
AR (1) AR020030A1 (xx)
AT (1) ATE392427T1 (xx)
AU (1) AU772283B2 (xx)
BG (1) BG106150A (xx)
BR (1) BR0011300A (xx)
CA (1) CA2372206C (xx)
CZ (1) CZ20014120A3 (xx)
DE (1) DE60038610T2 (xx)
DK (1) DK1189912T3 (xx)
DZ (1) DZ3043A1 (xx)
EA (1) EA003417B1 (xx)
ES (1) ES2302689T3 (xx)
GT (1) GT200000072A (xx)
HK (1) HK1045521B (xx)
HN (1) HN2000000056A (xx)
HR (1) HRP20010849A2 (xx)
HU (1) HUP0201341A3 (xx)
IL (2) IL145946A0 (xx)
IS (1) IS6127A (xx)
MA (1) MA26735A1 (xx)
MX (1) MXPA01011914A (xx)
MY (1) MY133397A (xx)
NO (1) NO320195B1 (xx)
NZ (1) NZ514765A (xx)
OA (1) OA11876A (xx)
PA (1) PA8495001A1 (xx)
PE (1) PE20010151A1 (xx)
PL (1) PL353316A1 (xx)
PT (1) PT1189912E (xx)
SK (1) SK16472001A3 (xx)
TN (1) TNSN00103A1 (xx)
TW (1) TWI225066B (xx)
UA (1) UA67842C2 (xx)
UY (1) UY26144A1 (xx)
WO (1) WO2000069874A1 (xx)
YU (1) YU76601A (xx)
ZA (1) ZA200109420B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
MXPA02007305A (es) 2000-01-27 2002-11-29 Pfizer Prod Inc Composiciones antiboticas de azalida.
JP4104463B2 (ja) * 2001-04-27 2008-06-18 ファイザー・プロダクツ・インク ４’’−置換された−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシン誘導体を製造するための方法
EP1435359A1 (en) * 2002-12-31 2004-07-07 Alembic Limited A process for the purification of roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
MA32997B1 (fr) * 2009-01-30 2012-01-02 Glaxo Group Ltd Macrolide anti-inflammatoire
EP2402355A1 (en) * 2010-07-01 2012-01-04 Novartis AG Crystalline anhydrous forms II and III of Tulathromycin
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN109942652B (zh) * 2017-12-21 2022-04-26 洛阳惠中兽药有限公司 一种莱柯霉素晶型ⅰ及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
HRP20010849A2 (en) 2003-04-30
IL145946A (en) 2007-06-17
KR100474229B1 (ko) 2005-03-08
KR20020007415A (ko) 2002-01-26
CN1351607A (zh) 2002-05-29
AP2001002325A0 (en) 2001-12-31
HK1045521A1 (en) 2002-11-29
NO20015598D0 (no) 2001-11-16
TNSN00103A1 (fr) 2005-11-10
GT200000072A (es) 2001-11-08
SK16472001A3 (sk) 2003-02-04
HK1045521B (zh) 2005-12-09
ES2302689T3 (es) 2008-08-01
HN2000000056A (es) 2001-02-02
EP1189912A1 (en) 2002-03-27
TWI225066B (en) 2004-12-11
MXPA01011914A (es) 2002-05-06
CA2372206A1 (en) 2000-11-23
HUP0201341A3 (en) 2003-03-28
EP1189912B1 (en) 2008-04-16
CA2372206C (en) 2006-01-10
CZ20014120A3 (cs) 2003-01-15
NO320195B1 (no) 2005-11-14
UA67842C2 (uk) 2004-07-15
EA003417B1 (ru) 2003-04-24
DE60038610T2 (de) 2009-06-25
YU76601A (sh) 2004-09-03
DE60038610D1 (de) 2008-05-29
JP2002544283A (ja) 2002-12-24
NO20015598L (no) 2002-01-08
CN1203084C (zh) 2005-05-25
BR0011300A (pt) 2002-02-26
US6583274B1 (en) 2003-06-24
DZ3043A1 (fr) 2004-03-27
MY133397A (en) 2007-11-30
EA200100984A1 (ru) 2002-06-27
UY26144A1 (es) 2000-12-29
OA11876A (en) 2006-03-27
IS6127A (is) 2001-10-26
DK1189912T3 (da) 2008-06-30
BG106150A (bg) 2002-05-31
AU3572900A (en) 2000-12-05
ZA200109420B (en) 2002-11-15
PA8495001A1 (es) 2002-02-21
AU772283B2 (en) 2004-04-22
AR020030A1 (es) 2002-03-27
HUP0201341A2 (en) 2002-08-28
WO2000069874A1 (en) 2000-11-23
ATE392427T1 (de) 2008-05-15
PT1189912E (pt) 2008-05-16
PL353316A1 (en) 2003-11-17
NZ514765A (en) 2004-05-28
JP3897983B2 (ja) 2007-03-28
PE20010151A1 (es) 2001-02-08
MA26735A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
EP1363925B8 (en) Macrolide antibiotics
PT2198858E (pt) Composição farmacêutica de libertação constante que contém um macrólido como o tacrolimus
AU2002217277A1 (en) Macrolide antibiotics
PL341647A1 (en) Novel derivatives of erythromycin
AU2001272719A1 (en) Macrolide antibiotics
IL142628A0 (en) Novel macrolide antibiotics
PL352296A1 (en) Crystalline derivatives of 1-methylocarbapeneme
ZA985655B (en) Crystalline macrolides
IL145256A0 (en) Erythromycin derivatives
IL145946A0 (en) Novel crystalline forms of a macrolide antibiotic
IL139793A0 (en) Crystalline efavirenz
AU6183700A (en) Erythromycin a derivatives
HK1045529A1 (en) A substantially crystalline form of melagatran
PL320688A1 (en) Derivatives of erythromycin a 9-0-oxime exhibiting antibiotic action
AU6316400A (en) Erythromycin a derivatives
AU6183800A (en) Erythromycin a derivatives
AU4942800A (en) Novel amorphous form of clarithromycin
EP1289913A4 (en) NEW ANTIBIOTIC COMPOUNDS
EP1200083A4 (en) ANTIBIOTIC COMPOUND
PL331688A1 (en) Method of obtaining 6-0-alkyl erythromycin a
AU5806101A (en) Novel antibiotic compounds
SI1196431T1 (sl) V bistvu kristalna oblika melagatrana
GB9800463D0 (en) Crystalline forms of antibiotic side chain intermediates
EP1261612A4 (en) CRYSTALLINE FORMS OF SIDE CHAIN INTERMEDIATES FOR ANTIBIOTICS
AU5693800A (en) Crystalline single diastereomers of 2-cyano-3-arylglutarate esters

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed